Madeline E. Waters, ARNP

Madeline Waters practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Madeline Waters' NPI, 1922486844, was assigned on May 12, 2015. Madeline Waters holds Florida license APRN9308862.

Madeline Waters' primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Madeline Waters' primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Madeline Waters to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Madeline Waters practices. Vendor and product names are available with a free account.

Nurse practitioner is Madeline Waters' primary specialty in the NPI Registry, under taxonomy code 363L00000X. Madeline Waters is licensed in Florida.

Dmand AI lists fluid and electrolyte imbalances and muscle pain, fibromyalgia, and limb pain among the conditions Madeline Waters treats.

CMS data shows 27 Medicare services from Madeline Waters across 2 procedure codes in 2024, all of them office visits, for 49 Medicare patients. Medicare paid $1,789 for them. Every service was in an office.

CMS counts 49 Medicare patients who saw Madeline Waters in 2024. The largest group is 75 to 84, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Madeline Waters' median patient age at 68, with 58% women.

In 2024, Madeline Waters wrote 371 Medicare Part D claims for 138 patients. 86% of them were for generic drugs. CMS names the drug for 250 of them, across 12 drugs with 11 or more claims each, at $23,883 in total drug cost.

Madeline Waters accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 255 general payments to Madeline Waters from 50 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 70% of the total. Catalyst Pharmaceuticals, Inc. paid the most, $3,135.